VERA Vera Therapeutics Inc

Price (delayed)

$43.44

Market cap

$2.37B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.25

Enterprise value

$2.37B

Highlights

The quick ratio has soared by 61% YoY and by 11% from the previous quarter

VERA's EPS is up by 33% year-on-year and by 22% since the previous quarter

VERA's equity is up by 32% year-on-year but it is down by 18% since the previous quarter

The net income has contracted by 8% YoY but it has grown by 7% from the previous quarter

VERA's debt has soared by 82% since the previous quarter and by 72% year-on-year

Sector: Healthcare

Industry: Biotechnology

Peers: OMER OMGA

Key stats

What are the main financial stats of VERA

Market

Shares outstanding

54.45M

Market cap

$2.37B

Enterprise value

$2.37B

Valuations

Price to earnings (P/E)

N/A

Price to book (P/B)

18.98

Price to sales (P/S)

N/A

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

N/A

Earnings

Revenue

EBIT

-$92.2M

EBITDA

-$94.07M

Free cash flow

-$92.24M

Per share

EPS

-$2.25

Free cash flow per share

-$2.16

Book value per share

$2.29

Revenue per share

TBVPS

$4.11

Balance sheet

Total assets

$175.55M

Total liabilities

$73.86M

Debt

$53.71M

Equity

$101.69M

Working capital

$149.72M

Liquidity

Debt to equity

0.53

Current ratio

7.71

Quick ratio

7.21

Net debt/EBITDA

-0.09

Margins

EBITDA margin

N/A

Gross margin

N/A

Net margin

N/A

Operating margin

N/A

Efficiency

Return on assets

-50.8%

Return on equity

-73.3%

Return on invested capital

-66.1%

Return on capital employed

-60.2%

Return on sales

N/A

Dividend

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

VERA stock price

How has the Vera Therapeutics stock price performed over time

Intraday

-0.14%

1 week

9.56%

1 month

9.7%

1 year

514.43%

YTD

182.44%

QTD

0.74%

Financial performance

How have Vera Therapeutics's revenue and profit performed over time

Revenue

Gross profit

Operating income

-$102.01M

Net income

-$95.99M

Gross margin

N/A

Net margin

N/A

VERA's operating income is down by 12% year-on-year but it is up by 6% since the previous quarter

The net income has contracted by 8% YoY but it has grown by 7% from the previous quarter

Growth

What is Vera Therapeutics's growth rate over time

Valuation

What is Vera Therapeutics stock price valuation

P/E

N/A

P/B

18.98

P/S

N/A

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

N/A

VERA's EPS is up by 33% year-on-year and by 22% since the previous quarter

VERA's equity is up by 32% year-on-year but it is down by 18% since the previous quarter

Efficiency

How efficient is Vera Therapeutics business performance

The ROIC has grown by 38% YoY and by 18% from the previous quarter

The ROA has increased by 18% year-on-year and by 12% since the previous quarter

VERA's return on equity is up by 11% since the previous quarter and by 10% year-on-year

Dividends

What is VERA's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for VERA.

Financial health

How did Vera Therapeutics financials performed over time

VERA's total assets is 138% greater than its total liabilities

The quick ratio has soared by 61% YoY and by 11% from the previous quarter

The company's current ratio has surged by 57% YoY and by 11% QoQ

VERA's debt is 47% smaller than its equity

Vera Therapeutics's debt to equity has surged by 121% QoQ and by 29% YoY

VERA's debt has soared by 82% since the previous quarter and by 72% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.